skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

8 Total results for product and free and sample content found

US Election 2020: Almost All House Members Backed By Industry PAC Dollars Retain Seats

16 Jun 2022

Out of 31 US House incumbents supported by high amounts of medtech industry political action committee (PAC) dollars, only one – Chrissy Houlahan of Pennsylvania – lost in last week’s election.

Topic us-election-2020 policy-and-regulation Legislation

California Plans To Create Own Generics Label

27 Nov 2020

California’s 2020-2021 fiscal budget includes plans to work with manufacturers to establish the state’s own generics label. But industry is sceptical that the initiative will deliver the savings that the US state hopes for.

Topic Legislation policy-and-regulation

All About Value – Brexit Aside, UK Industry Sees Good Things Ahead For Healthtech Adoption

27 Nov 2020

ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.

Topic Medtech-Brexit EU Legislation Regulation

US Election 2020: Industry Loses Three Favored Incumbents In Battle For Senate Control

18 Nov 2020

A few of the US Senate candidates favored and given tens of thousands of dollars by industry have lost their battles for re-election

Topic us-election-2020 Legislation

Biopharma Needs A Deal On Drug Pricing As Shield Against Possible Democrat Wins - BIO's Greenwood

21 Sep 2020

Outgoing Biotechnology Innovation Organization CEO suggests consideration of price inflation caps instead of 'big discounts' in Medicare Part D and says that industry should fund a cap on beneficiary out-of-pocket costs in the program.

Topic us-election-2020 drug-pricing Legislation

Mylan/Biocon's Insulin Glargine Would Get A Respite Under US Budget Legislation

18 Dec 2019

Bill addresses ‘dead zone’ for pending applications for protein products transitioning to biologic status; generic and brand industries each win in different legislative provisions: inclusion of the CREATES Act, and a revised definition for ‘biologics’ that includes chemically synthesized polypeptides.

Topic biosimilars Legislation

Outlook 2020 Report

18 Dec 2019

Tap Outlook 2020’s essential coverage of medtech, R&D, clinical trials and regulation, manufacturing, and more with your extract from our most powerful report.

Topic Outlook Medtech M A Manufacturing Market Intelligence Regulation Legislation Leadership

HBW Insight

US Senate Passes First Monograph Reform Bill After House Passed Three

11 Dec 2019

Article

Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.

Topic fda Legislation OTC Drugs

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: